Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) have been assigned a consensus recommendation of “Hold” from the eighteen analysts that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and six have issued a buy rating on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $9.7969.
TDOC has been the subject of a number of research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Teladoc Health in a research report on Saturday, September 27th. Evercore ISI upped their target price on Teladoc Health from $7.00 to $8.00 and gave the stock an “in-line” rating in a research report on Wednesday, July 9th. Finally, Mizuho assumed coverage on Teladoc Health in a research note on Friday, July 25th. They issued a “neutral” rating and a $10.00 target price for the company.
Check Out Our Latest Research Report on Teladoc Health
Institutional Trading of Teladoc Health
Teladoc Health Stock Up 6.2%
TDOC opened at $9.01 on Friday. Teladoc Health has a 1 year low of $6.35 and a 1 year high of $15.21. The firm has a 50 day moving average price of $7.66 and a 200 day moving average price of $7.60. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. The company has a market cap of $1.59 billion, a PE ratio of -7.57 and a beta of 1.90.
Teladoc Health (NYSE:TDOC – Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The company had revenue of $631.90 million during the quarter, compared to the consensus estimate of $621.91 million. During the same period in the previous year, the firm earned ($0.38) earnings per share. Teladoc Health’s revenue for the quarter was down 1.6% on a year-over-year basis. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS. Sell-side analysts expect that Teladoc Health will post -1.16 earnings per share for the current year.
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
- Five stocks we like better than Teladoc Health
- How to Use Stock Screeners to Find Stocks
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?
- How to Profit From Value Investing
- Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Forget Airlines—These Trucking Stocks Are Shifting Into High Gear
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.